| David Shapiro, DO | |
|
1105 Sixth St, Traverse City, MI 49684-2349 | |
| (231) 395-6333 | |
| (801) 740-2847 |
| Full Name | David Shapiro |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1105 Sixth St, Traverse City, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194921387 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101015945 (Michigan) | Primary |
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
When it comes to how much end-of-life care a patient with cancer receives, geography may, indeed, be destiny, according to new research led by Harvard Medical School that found striking differences in terminal care across different parts of the country.
In the meantime, a new poll suggests the problems with the health law rollout have harmed the public's view of the law as a whole, and a second poll suggests the public sees addressing health care costs as the central issue.
Aging may seem unavoidable, but that's not necessarily so when it comes to the brain. So say researchers in the April 27th issue of the Cell Press journal Trends in Cognitive Sciences explaining that it is what you do in old age that matters more when it comes to maintaining a youthful brain not what you did earlier in life.
Paxman Scalp Cooling System has been named as one of Cleveland Clinic's Top 10 Medical Innovations of 2018. The list of up-and-coming technologies was selected by a panel of Cleveland Clinic physicians and scientists and was announced at a presentation at the 2017 Medical Innovation Summit.
› Verified 5 days ago
| Entity Name | Kalkaska Memorial Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013183060 PECOS PAC ID: 3577536002 Enrollment ID: O20040813000668 |
News Archive
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
When it comes to how much end-of-life care a patient with cancer receives, geography may, indeed, be destiny, according to new research led by Harvard Medical School that found striking differences in terminal care across different parts of the country.
In the meantime, a new poll suggests the problems with the health law rollout have harmed the public's view of the law as a whole, and a second poll suggests the public sees addressing health care costs as the central issue.
Aging may seem unavoidable, but that's not necessarily so when it comes to the brain. So say researchers in the April 27th issue of the Cell Press journal Trends in Cognitive Sciences explaining that it is what you do in old age that matters more when it comes to maintaining a youthful brain not what you did earlier in life.
Paxman Scalp Cooling System has been named as one of Cleveland Clinic's Top 10 Medical Innovations of 2018. The list of up-and-coming technologies was selected by a panel of Cleveland Clinic physicians and scientists and was announced at a presentation at the 2017 Medical Innovation Summit.
› Verified 5 days ago
| Entity Name | Northwestern Michigan Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073597944 PECOS PAC ID: 7214933928 Enrollment ID: O20061019000359 |
News Archive
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
When it comes to how much end-of-life care a patient with cancer receives, geography may, indeed, be destiny, according to new research led by Harvard Medical School that found striking differences in terminal care across different parts of the country.
In the meantime, a new poll suggests the problems with the health law rollout have harmed the public's view of the law as a whole, and a second poll suggests the public sees addressing health care costs as the central issue.
Aging may seem unavoidable, but that's not necessarily so when it comes to the brain. So say researchers in the April 27th issue of the Cell Press journal Trends in Cognitive Sciences explaining that it is what you do in old age that matters more when it comes to maintaining a youthful brain not what you did earlier in life.
Paxman Scalp Cooling System has been named as one of Cleveland Clinic's Top 10 Medical Innovations of 2018. The list of up-and-coming technologies was selected by a panel of Cleveland Clinic physicians and scientists and was announced at a presentation at the 2017 Medical Innovation Summit.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Shapiro, DO 1105 Sixth St, Traverse City, MI 49684-2349 Ph: (231) 947-0673 | David Shapiro, DO 1105 Sixth St, Traverse City, MI 49684-2349 Ph: (231) 395-6333 |
News Archive
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
When it comes to how much end-of-life care a patient with cancer receives, geography may, indeed, be destiny, according to new research led by Harvard Medical School that found striking differences in terminal care across different parts of the country.
In the meantime, a new poll suggests the problems with the health law rollout have harmed the public's view of the law as a whole, and a second poll suggests the public sees addressing health care costs as the central issue.
Aging may seem unavoidable, but that's not necessarily so when it comes to the brain. So say researchers in the April 27th issue of the Cell Press journal Trends in Cognitive Sciences explaining that it is what you do in old age that matters more when it comes to maintaining a youthful brain not what you did earlier in life.
Paxman Scalp Cooling System has been named as one of Cleveland Clinic's Top 10 Medical Innovations of 2018. The list of up-and-coming technologies was selected by a panel of Cleveland Clinic physicians and scientists and was announced at a presentation at the 2017 Medical Innovation Summit.
› Verified 5 days ago
Bevin Clayton, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 Fax: 801-740-2847 | |
Dale C Blum, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 Fax: 801-740-2847 | |
Dr. Brandi Jenks Gunn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 Fax: 801-740-2847 | |
Richard G Faller, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 Fax: 801-740-2847 | |
David Darwin Nicolaou, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Munson Ave, Traverse City, MI 49686 Phone: 231-935-8710 | |
Juhn Mark Han, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1105 6th St, Traverse City, MI 49684 Phone: 231-947-0673 |